InvestorsHub Logo
Followers 0
Posts 23
Boards Moderated 0
Alias Born 03/20/2015

Re: None

Thursday, 11/03/2016 4:36:19 PM

Thursday, November 03, 2016 4:36:19 PM

Post# of 38634
Maxim Group called me again today and spoke about Seroquel XR.

Keith told me annual sales are $1.2B. When generics come into play it could shrink to $600M. 10% market share for IPCI would be $60M. Split that with Mallinkrodt cuts it to $30M in sales. Then anticipate 80% gross profit. Thus a reasonable estimate would be $20M to $25M annaully.